Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7310
+0.0210 (2.96%)
At close: May 12, 2025, 4:00 PM
1.230
+0.499 (68.26%)
After-hours: May 12, 2025, 7:59 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $37.85 million as of May 12, 2025. Its market cap has increased by 3.59% in one year.
Market Cap
37.85M
Enterprise Value
-51.23M
1-Year Change
3.59%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $37.85M, a decrease of -91.13%. That is a compound annual growth rate of -49.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 36.76M | -15.81% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |